NCT06711081

Brief Summary

This in-vivo study aims to evaluate the efficacy of the low level laser therapy and cryotherapy in treatment of vital pulpotomy in mature permanent molar evaluating the post operative pain and the radiographic changes in pulpal and periodontal regions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

November 22, 2024

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

1 month

First QC Date

November 22, 2024

Last Update Submit

November 28, 2024

Conditions

Keywords

vital pulp therapy permanent teeth pulpotomy LLLT

Outcome Measures

Primary Outcomes (1)

  • radiographic changes

    and x-ray change either pulpal or periapical using CBCT subtraction

    one year after treatment

Secondary Outcomes (1)

  • Post operative pain

    one week after treatment

Study Arms (3)

• Group I: Conventional complete Pulpotomy using MTA (control group).

NO INTERVENTION

MTA putty material will be placed using premixed capsule which will be triturated according to manufacturer's instructions. MTA will be placed in a 2-3 mm layer above the pulp tissue using an amalgam carrier and gently packed to the canal orifice using a condenser, then it will be covered by moistened cotton pellet for 2 minutes to achieve the initial setting, then the cotton pellet will be removed. A layer of resin modified glass ionomer cement will be placed and the tooth will be restored using light cured composite filling material .

• Group II: LLLT following complete pulpotomy.

ACTIVE COMPARATOR

after achieving homeostasis, LLLT will be applied using diode laser of 810 nm wave length with energy of 2 J/cm2 under a continuous mode with power output of 100 mW for about 10 sec with laser tip size 600 μm and 2 mm away from the canal orifice, Then MTA will be placed and the tooth will be restored as in group I.

Device: low level laser device cryotherapy

• Group III: Cryotherapy following complete pulpotomy.

ACTIVE COMPARATOR

after achievement of homeostasis, the cryotherapy will be applied using small piece of shaved sterile ice wrapped with sterile piece of gauze (0° Celsius) which will be placed over the pulpal tissue in the pulp chamber. After approximately 60 seconds, the molten ice will be removed, then MTA will be placed and the tooth will be restored as in group I.

Device: low level laser device cryotherapy

Interventions

using new device direct on the pulp tissue

Also known as: cryotherapy
• Group II: LLLT following complete pulpotomy.• Group III: Cryotherapy following complete pulpotomy.

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Restorable vital and mature mandibular molar teeth with irreversible pulpitis.
  • Teeth with deep caries or large restoration.
  • Pre-operative radiograph showing normal periapical structure.
  • Teeth with normal periodontal status .

You may not qualify if:

  • Medically compromised patients with active systemic disease as uncontrolled diabetes mellitus, hypertension or cardiac diseases.
  • Teeth with periapical lesion.
  • Sinus tract or swelling.
  • Moderate or severe marginal periodontitis.
  • Patient allergic to any material or medication used in this study.
  • Teeth with moderate to severe mobility.
  • Teeth with periodontal diseases.
  • Teeth with anatomical variations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry

Tanta, Egypt

RECRUITING

Related Publications (2)

  • Murray PE. Review of guidance for the selection of regenerative endodontics, apexogenesis, apexification, pulpotomy, and other endodontic treatments for immature permanent teeth. Int Endod J. 2023 Mar;56 Suppl 2:188-199. doi: 10.1111/iej.13809. Epub 2022 Aug 15.

    PMID: 35929348BACKGROUND
  • Duncan HF, El-Karim I, Dummer PMH, Whitworth J, Nagendrababu V. Factors that influence the outcome of pulpotomy in permanent teeth. Int Endod J. 2023 Mar;56 Suppl 2:62-81. doi: 10.1111/iej.13866. Epub 2022 Nov 22.

    PMID: 36334098BACKGROUND

MeSH Terms

Interventions

Cryotherapy

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • abeer darrag, phd

    Professor of Endodontics

    PRINCIPAL INVESTIGATOR
  • tokka moukhatar

    Lecturer of Endodontics

    STUDY DIRECTOR

Central Study Contacts

mohamed motiea, bachelor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

November 22, 2024

First Posted

December 2, 2024

Study Start

November 1, 2024

Primary Completion

December 1, 2024

Study Completion

November 1, 2025

Last Updated

December 2, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations